USPSTF: Evidence Lacking for Screening Children for Prediabetes, T2D
TUESDAY, Sept. 13, 2022 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) concludes that evidence is insufficient to recommend for or against screening children or adolescents for prediabetes or type 2 diabetes. These findings form …
Learn MoreWomen With Migraines Face Higher Odds for Complications in Pregnancy
TUESDAY, Sept. 13, 2022 (HealthDay News) — A history of migraine headaches could make a woman more prone to pregnancy complications, such as issues with blood pressure or preterm birth, according to a new study.”We now know migraines may be an underr…
Learn MoreUn medicamento experimental se muestra promisorio contra el lupus
JUEVES, 8 de septiembre de 2022 (HealthDay News) — Un medicamento experimental, que se ha demostrado que puede tratar los sarpullidos en las personas con lupus, también podría ayudar con el dolor de las articulaciones relacionados con el lupus.El lup…
Learn MorePressure Injury Prediction Tool Lacking for Severe COVID-19 Patients
FRIDAY, Sept. 9, 2022 (HealthDay News) — Critically ill patients with COVID-19 have a high risk for hospital-acquired pressure injury, with the Braden Scale providing only poor-to-fair predictive discrimination, according to a study recently publis…
Learn MoreDogs Have Died After Licking a Common Chemotherapy Cream, FDA Warns
FRIDAY, Sept. 9, 2022 (HealthDay News) — Your dog may like to lick your hand or face, but if you’re using a chemotherapy cream that treats certain skin conditions, you should not allow it, the U.S. Food and Drug Administration advises.The medication …
Learn MoreForehead Thermometers May Miss Fevers in Black Patients
THURSDAY, Sept. 8, 2022 (HealthDay News) — Thermometers that read body temperature via the forehead have become a common sight throughout the pandemic, but whether they always spot a fever may depend on the color of someone’s skin. In a new study, re…
Learn MoreReduction in Swollen, Tender Joints Greater With Litifilimab in Lupus
THURSDAY, Sept. 8, 2022 (HealthDay News) — Patients with systemic lupus erythematosus (SLE) receiving litifilimab, a humanized monoclonal antibody that binds to blood dendritic cell antigen 2, versus placebo have a greater reduction in the number of …
Learn MoreRisk for MGUS Up in WTC-Exposed Rescue/Recovery Workers
THURSDAY, Sept. 8, 2022 (HealthDay News) — World Trade Center (WTC)-exposed rescue/recovery workers have an increased risk for the myeloma precursor disease monoclonal gammopathy of undetermined significance (MGUS), according to a study published o…
Learn MoreExperimental Drug Shows Promise Against Lupus
THURSDAY, Sept. 8, 2022 (HealthDay News) — An experimental drug that has been shown to treat rashes in people with lupus may also help with lupus-related joint pain.Affecting as many as 1.5 million people in the United States, lupus is an autoimmune …
Learn MoreExperimental Drug Shows Promise Against Lupus
THURSDAY, Sept. 8, 2022 (HealthDay News) — An experimental drug that has been shown to treat rashes in people with lupus may also help with lupus-related joint pain.Affecting as many as 1.5 million people in the United States, lupus is an autoimmune …
Learn More